Ledger.Open graph →
SEC Form D · filed May 15, 2017

Sienna Biopharmaceuticals, Inc

Offering
$40.5M
Sold
$40.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Weslake Village, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Frederick C. Beddingfield Iii · Westlake Village, CAExec · DirectorRobert R. Nelsen · Westlake Village, CADirectorGeorgia M. Erbez · La Jolla, CAExec · DirectorKristina R. Burow · Westlake Village, CADirectorDennis R. Fenton · Westlake Village, CADirectorDennis R. Fenton · Westlake Village, CADirectorRic C. Peterson · Westlake Village, CAExecQuoc Ngo · Boise, IDExecFrederick C. Beddingfield Iii · Westlake Village, CAExec · DirectorTimothy K. Andrews · Westlake Village, CAExecDiane F. Stroehmann · Westlake Village, CAExecThom Ives · Boise, IDExecGene Gutman · Menomonie, WIExecRobert R. Nelsen · Westlake Village, CADirectorBob R. More · Westlake Village, CADirectorTodd C. Harris · Westlake Village, CAExec · DirectorPaul F. Lizzul · Westlake Village, CAExecArie N. Page · Vancouver, British Columbia, CanadaExecPaul Burton · Boise, IDExecJohn J. Mccleary · Vancouver, British Columbia, CanadaExecBob R. More · Westlake Village, CADirectorKeith R. Leonard Jr · Westlake Village, CADirectorRic C. Peterson · Westlake Village, CAExecKristina R. Burow · Westlake Village, CADirectorKeith R. Leonard Jr · Westlake Village, CADirectorRita J. King · Morrisville, NCExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗